Robert A. Ortenzio Sells 46,611 Shares of Select Medical Holdings (SEM) Stock

Select Medical Holdings (NYSE:SEM) Chairman Robert A. Ortenzio sold 46,611 shares of the business’s stock in a transaction dated Wednesday, May 16th. The shares were sold at an average price of $18.52, for a total value of $863,235.72. Following the completion of the sale, the chairman now owns 7,225,885 shares in the company, valued at $133,823,390.20. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of SEM opened at $18.40 on Friday. Select Medical Holdings has a twelve month low of $13.30 and a twelve month high of $19.77. The stock has a market cap of $2.48 billion, a PE ratio of 18.97, a P/E/G ratio of 1.25 and a beta of 1.30. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 3.60.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, May 3rd. The health services provider reported $0.29 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.03. Select Medical had a return on equity of 15.19% and a net margin of 4.23%. The firm had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.23 billion. During the same period in the prior year, the business posted $0.21 earnings per share. The company’s revenue was up 14.7% on a year-over-year basis. sell-side analysts predict that Select Medical Holdings will post 1.05 earnings per share for the current fiscal year.

A number of equities research analysts recently issued reports on the company. Zacks Investment Research cut Select Medical from a “hold” rating to a “sell” rating in a research note on Friday, May 11th. ValuEngine cut Select Medical from a “strong-buy” rating to a “buy” rating in a research report on Monday, May 7th. Robert W. Baird reiterated a “buy” rating and set a $26.00 price target on shares of Select Medical in a research report on Friday, February 23rd. Finally, TheStreet cut Select Medical from a “b-” rating to a “c+” rating in a research report on Friday, February 2nd. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $20.63.

Several institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. increased its position in shares of Select Medical by 1.4% in the first quarter. BlackRock Inc. now owns 14,032,703 shares of the health services provider’s stock worth $242,062,000 after purchasing an additional 196,009 shares during the last quarter. Hood River Capital Management LLC increased its position in shares of Select Medical by 1.3% in the first quarter. Hood River Capital Management LLC now owns 2,437,544 shares of the health services provider’s stock worth $42,048,000 after purchasing an additional 30,112 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of Select Medical by 39.0% in the first quarter. Victory Capital Management Inc. now owns 1,740,986 shares of the health services provider’s stock worth $30,032,000 after purchasing an additional 488,636 shares during the last quarter. Millennium Management LLC increased its position in shares of Select Medical by 17.4% in the first quarter. Millennium Management LLC now owns 1,292,387 shares of the health services provider’s stock worth $22,294,000 after purchasing an additional 191,715 shares during the last quarter. Finally, Boston Partners increased its position in shares of Select Medical by 7.7% in the fourth quarter. Boston Partners now owns 896,050 shares of the health services provider’s stock worth $15,815,000 after purchasing an additional 64,003 shares during the last quarter. Hedge funds and other institutional investors own 77.28% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.

Insider Buying and Selling by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply